Clinical Report: Exploring Animal Models of Pyruvate Dehydrogenase Complex Deficiency

Overview

This review highlights the use of animal models to study primary pyruvate dehydrogenase complex (PDC) deficiency, focusing on cerebral abnormalities and metabolic roles.

Background

Primary PDC deficiency is a mitochondrial disorder that significantly impacts carbohydrate metabolism and has severe neurological consequences. The condition is primarily caused by mutations in the PDHA1 gene, leading to a heterogeneous clinical presentation. Understanding the mechanisms and effects of PDC deficiency through animal models is crucial for developing therapeutic strategies.

Data Highlights

No numerical data or trial data was provided in the source material.

Key Findings

• Mouse models of PDC deficiency replicate several cerebral abnormalities seen in affected individuals.
• Animal models provide insights into cellular processes such as proliferation, migration, and differentiation affected by PDC deficiency.
• Creation of tissue-specific PDC deficiency models is essential for studying carbohydrate metabolism.
• All current animal models have null mutations in PDC genes, indicating a need for models with missense mutations to explore genotype-phenotype relationships.
• Animal models are valuable for screening potential dietary and drug treatments for PDC deficiency.

Clinical Implications

Animal models of PDC deficiency can aid in understanding the disease's pathophysiology and the impact of various treatments.

Conclusion

The use of animal models is pivotal in advancing the understanding of primary PDC deficiency.

Related Resources & Content

1. A Nationwide Study of Pyruvate Dehydrogenase Complex Deficiency in Sweden | Neurology
2. Pyruvate Dehydrogenase Complex Deficiency: A Review of Treatments and Case Series
3. Brain — Modulating Lipid Droplets in FUS-Associated Amyotrophic Lateral Sclerosis Reduces Lipotoxic Effects on Neurons and Astrocytes
4. Acta Neuropathologica — Tauroursodeoxycholic acid halts axonal degeneration by suppressing the unfolded protein response in X-linked adrenoleukodystrophy
5. Acta Neuropathologica — Disruption of the mitochondrial enzyme SHMT2 involved in one-carbon metabolism leads to a unique syndrome affecting brain and heart development
6. Acta Neuropathologica — Understanding the Foundations of Clinicopathological Variability in TDP-43 Proteinopathies
7. A Nationwide Study of Pyruvate Dehydrogenase Complex Deficiency in Sweden | Neurology
8. Pyruvate Dehydrogenase Complex Deficiency: A Review of Treatments and Case Series
9. Next Generation AAV-F Capsid gene therapy rescues disease pathology in a model of Pyruvate Dehydrogenase Complex Deficiency | Sciety Labs (Experimental)